Estrogen receptor blockade and radiation therapy cooperate to enhance the response of immunologically cold ER+ breast cancer to immunotherapy.

Breast Cancer Res · 2023 · PMC10265911 · PMID 37312163

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

As a monotherapy, fulvestrant showed a trend to reduce several intratumoral immune populations, including Ly6C+/Ly6G+ and F4/80+ myeloid cells and FOXP3+ lymphocytes, compared to control recipients at varying stages of the estrous cycle.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.